CAS RN: 29964-62-3
[1,4-Bis(diphenylphosphino)butane]palladium(II) Dichloride
Product Availability
Choose a grade to view its available package options.
5 package records3 with current stock1 grade group
| Batch No. | Package | Availability | Inquiry |
| Batchno.20250218 |
10g |
In stock |
Inquiry |
| Batchno.20250803 |
1g |
In stock |
Inquiry |
| Batchno.20250817 |
250mg |
In stock |
Inquiry |
| Batchno.20260319 |
25g |
Out of stock |
Inquiry |
| Batchno.20250203 |
5g |
Out of stock |
Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.25g, 1g, 5g, 10g, 25g
- Available purity: ≥97%
- Inventory rows with stock: 1
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 29964-62-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.25g |
≥97% |
1
In Stock
|
Shanghai |
Inquiry |
| 1g |
≥97% |
0
Out of Stock
|
Shenzhen |
Inquiry |
| 5g |
≥97% |
0
Out of Stock
|
Hong Kong |
Inquiry |
| 10g |
≥97% |
0
Out of Stock
|
Beijing |
Inquiry |
| 25g |
≥97% |
0
Out of Stock
|
Beijing |
Inquiry |
29964-62-3 / dichloropalladium;4-diphenylphosphanylbutyl(diphenyl)phosphane
Standard CAS: 29964-62-3
Multi CAS: Yes
Basic Information
CAS
29964-62-3
Multi CAS
Yes
Molecular Formula
C28H28CL2P2PD
Molecular Weight
603.800000
Exact Mass
602.007810
InChI
InChI=1S/C28H28P2.2ClH.Pd/c1-5-15-25(16-6-1)29(26-17-7-2-8-18-26)23-13-14-24-30(27-19-9-3-10-20-27)28-21-11-4-12-22-28;;;/h1-12,15-22H,13-14,23-24H2;2*1H;/q;;;+2/p-2
InChIKey
JQXJBXVWVPVTOO-UHFFFAOYSA-L
Computed Properties
Structural Parameters
Heavy atom count
33
Aromatic heavy atom count
24
Fraction Csp3
0.14
Rotatable bonds
9
Molar refractivity
148.82
TPSA
0.0000
LogP / Solubility
WLOGP
7.41
MLOGP
6.57
XLogP3
7.41
Consensus LogP
7.13
Log S (ESOL)
-8.2
Class (ESOL)
Insoluble
Log S (Ali)
-9.86
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.81
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.14
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
3